Blog: Drug Injury - Page 3

The CEO of Aegerion Pharmaceuticals, which manufactures popular cholesterol drug Juxtapid, recently went on CNBC’s Fast Money to talk about the drug. During his interview, the CEO stated that Juxtapid could prevent heart attacks and lengthen life, though neither claim has been studied or approved. Dangerous drug lawyers at Pintas & Mullins Law Firm see this type of …

The Centers for Disease Control and Prevention (CDC) recently issued a media statement informing hospitals and patients that at least one lot of the Gardasil HPV vaccine has been recalled due to glass contamination. Gardasil’s manufacturer, Merck, voluntarily recalled over 743,000 shipments, which went out between August 20 and October 9, 2013. Gardasil attorneys at Pintas & Mullins Law …

Oral tablets of paroxetine has been on American markets since 1993 to treat an array of mental disorders, such as anxiety and OCD, and is now being re-branded to treat hot flashes in menopausal women. The problem with this re-branding is that paroxetine is just the generic name for the hotly contested antidepressant Paxil, which …

The FDA recently issued a Drug Safety Communication warning patients and physicians of the rare but extremely serious health risks associated with Onfi, an anti-seizure medication. There have been numerous reports of Onfi patients being diagnosed with Stevens-Johnson Syndrome (SJS) and its more severe form, toxic epidermal necrolysis (TEN), at least one of which resulted …

Litigation concerning jaw injuries from osteoporosis drug Fosamax have finally settled, with plaintiffs receiving a total of $27.7 million. This settlement resolves the drawn-out multidistrict litigation (MDL) over bone death, or osteonecrosis, in Fosamax patients’ jaws. Our Fosamax attorneys point out that this settlement does not resolve claims concerning femur fractures caused by the same drug. Merck …

The FDA recently warned consumers and physicians about the dangerous and potentially life-threatening reactions the popular seizure drug, Onfi, may cause. Onfi’s labels will soon be changed to reflect the possibility of devastating skin reactions, which is most prevalent during the first two months of treatment. Stevens-Johnson Syndrome lawyers at Pintas & Mullins Law Firm highlight this …

The FDA recently informed healthcare providers throughout the U.S. to avoid using heart stress test drugs manufactured by Astellas Pharma due to reports of heart attacks and deaths in patients. The drugs, Adenoscan and Lexiscan, are injected to determine whether patients have blocked heart arteries. Dangerous drug attorneys at Pintas & Mullins Law Firm warn cardiac patients …

The United States makes up 5% of the world’s population, though it consumes 99% of the global hydrocodone supply, 80% of the oxycodone, and 65% of the hydromorphone, according to an article recently published by the New Yorker. The piece was written by a young medical doctor, who has seen first-hand the rise and consequences of prescription narcotic …

In an exciting and unprecedented decision, the FDA recently proposed a new rule that would allow generic drug manufacturers to update labels independently from their brand-name counterparts. This has been an issue of hot debate over the past decade or so, as plaintiffs injured by generic drugs attempt to sue generic companies for failure-to-warn. Presently, …

As part of the new provisions for the Affordable Care Act (aka Obamacare), the Department of Health and Human Services (HHS) recently ruled that drug manufacturers will be able to help pay for many patients’ branded drug expenses. The decision, lauded by Big Pharma but criticized by health plans, clarifies the extent to which drug …

Dangerous drug lawyers at Pintas & Mullins Law Firm know through extensive experience that a black box warning clearly indicates that a medication is inherently and excessively dangerous. Black box warnings are added to drug labels by the FDA when there is clear, scientific evidence that the drug poses a significant health risk or can cause …

Prempro lawyers at Pintas & Mullins Law Firm confirm that the Pennsylvania Supreme Court recently rejected Wyeth Pharmaceutical’s attempt to appeal an $11.3 million jury verdict concerning its menopause drug Prempro. The plaintiff in this case alleged that the drug caused her to develop breast cancer. The case initially concluded in January 2010, when the three-judge …

Drug recall lawyers at Pintas & Mullins Law Firm announce that the FDA recently recalled several lots of injectable antibiotics due to metal, cotton, and hair contamination. The antibiotics, Maxipime (cefepime) and dextrose, are commonly used to treat pneumonia, as well as skin, abdominal, and urinary tract infections. The antibiotics are manufactured by B. Braun Medical …

Dangerous drug lawyers at Pintas & Mullins Law Firm confirm that the FDA recently issued a warning to healthcare professionals about the risk of blood clots in patients taking Iclusig (ponatinib). Due to higher than expected reports of life-threatening blood clots and narrowing of blood vessels, the FDA is opening an investigation and recommending physicians reconsider …

Fungal meningitis lawyers at Pintas & Mullins Law Firm confirm that at least one patient has relapsed one full year after the outbreak of fungal meningitis. Medical officials in Tennessee are currently contacting other original victims to chick on their health status. Fortunately, the relapsed patient was admitted to the hospital in time and is now …

Drug recall lawyers at Pintas & Mullins Law Firm confirm that Hospira Inc. recently announced a recall of three lots of injectable drugs due to glass contamination. The company stated that the strands of glass could dislodge and harm patients if injected, and blamed one of its suppliers for the defects. The glass particles can detach …

Dangerous drug lawyers at Pintas & Mullins Law Firm report that the FDA recently issued a safety warning about the potential for adverse side effects from Asthmanefrin (racepinephrine), an over-the-counter asthma drug. The FDA has received an abundance of complaints about the inhaled solution this past year. Asthmanefrin is manufactured by Nephron Pharmaceuticals Corp., and was …

Plavix lawyers at Pintas & Mullins Law Firm report that dozens of plaintiffs have filed suit against manufacturers Sanofi and Bristol-Myers Squibb over the blood-thinner Plavix (clopidogrel). Patients in the U.S. and abroad are claiming the drug made them develop autoimmune diseases and suffer severe hemorrhages. U.S. plaintiffs took their claims to New York state court …

Compounding pharmacy lawyers at Pintas & Mullins Law Firm report on a rare feat of bipartisan agreement for a new bill that will increase federal oversight of compounding pharmacies. Leaders in the House and Senate announced the new legislation, which calls for a new tracing system to track prescription drug sales from manufacturing through distribution. The …